Caspase inhibitors protect against neuronal apoptosis induced by cerebrospinal fluid from multiple sclerosis patients

Journal of Neuroimmunology

Volumn 136, Issue 1-2, 2003, Pages 119-124

  Cid, C ^a   Alvarez Cermeno J C ^a,b   Regidor, I ^a   Plaza, J ^a   Salinas, M ^a   Alcazar A ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Apoptosis; Caspase inhibitors; Caspase 3; Cerebrospinal fluid; Cultured neurons; Multiple sclerosis

Indexed keywords

CASPASE 3; CASPASE INHIBITOR; COUMARIN DERIVATIVE; DNA FRAGMENT; INTERLEUKIN 1BETA CONVERTING ENZYME; N ACETYLASPARTYLGLUTAMYLVALYLASPARTYL 7 AMINO 4 METHYLCOUMARIN; N ACETYLTYROSYLVALYLALANYLASPARTYL 7 AMINO 4 METHYLCOUMARIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADOPTIVE IMMUNOTHERAPY; ADULT; ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CELL CULTURE; CELL PROTECTION; CELL SURVIVAL; CEREBROSPINAL FLUID; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; ENZYME ACTIVITY; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

EID: 0344406722     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00467-8     Document Type: Article

References (25)

1. Adams J.M., Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 281:1998;1322-1326.
2. Alcázar A., Regidor I., Masjuan J., Salinas M., Álvarez-Cermeño J.C. Induction of apoptosis by cerebrospinal fluid from patients with primary-progressive multiple sclerosis in cultured neurons. Neurosci. Lett. 255:1998;75-78.
3. Alcázar A., Regidor I., Masjuan J., Salinas M., Álvarez-Cermeño J.C. Axonal damage induced by cerebrospinal fluid from patients with relapsing-remitting multiple sclerosis. J. Neuroimmunol. 104:2000;58-67.
4. Ashkenazi A., Dixit V.M. Death receptors: signaling and modulation. Science. 281:1998;1305-1308.
5. Bottenstein J.E., Sato G.H. Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc. Natl. Acad. Sci. U. S. A. 76:1979;514-517.
6. Cid C., Alcázar A., Regidor I., Masjuan J., Salinas M., Alvarez-Cermeño J.C. Neuronal apoptosis induced by cerebrospinal fluid from multiple sclerosis patients correlates with hypointense lesions on T1 magnetic resonance imaging. J. Neurol. Sci. 193:2002;103-109.
7. Earnshaw W.C. Nuclear changes in apoptosis. Curr. Opin. Cell Biol. 7:1995;337-343.
8. Furlan R., Filippi M., Bergami A., Rocca M.A., Martinelli V., Poliani P.L., Grimaldi L.M.E., Desina G., Comi G., Martino G. Peripheral levels of caspase-1 mRNA correlate with disease activity in patients with multiple sclerosis: a preliminary study. J. Neurol. Neurosurg. Psychiatry. 67:1999;785-788.
9. Furlan R., Martino G., Galbiati F., Poliani P.L., Smiroldo S., Bergami A., Desina G., Comi G., Flavell R., Su M.S., Adorini L. Caspase-1 regulates the inflammatory process leading to autoimmune demyelination. J. Immunol. 63:1999;2403-2409.
10. Genain C.P., Cannella B., Hauser S.L., Raine C.S. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 5:1999;170-175.
11. Jiang D., Jha N., Boonplueang R., Andersen J.K. Caspase 3 inhibition attenuates hydrogen peroxide-induced DNA fragmentation but not cell death in neuronal PC12 cells. J. Neurochem. 76:2001;1745-1755.
12. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 33:1983;1444-1452.
13. Kurtzke J.F., Beebe G., Nagler B., Auth T., Kurland L., Nefzger M. Studies on the natural history of multiple sclerosis. Correlates of clinical change in an early bout. Acta Neurol. Scand. 49:1973;379-395.
14. Meyer R., Weissert R., Diem R., Storch M.K., De Graaf K.L., Kramer B., Bähr M. Acute neuronal apoptosis in a rat model of multiple sclerosis. J. Neurosci. 15:2001;6214-6220.
15. Nicholson D.W., Thornberry N.A. Caspases: killer proteases. Trends Biochem. Sci. 22:1997;299-306.
16. Noseworthy J.H. Progress in determining the causes and treatment of multiple sclerosis. Nature. 399:1999;A40-A47.
17. Noseworthy J.H., Lucchinetti C., Rodriguez M., Weinshenker B.G. Multiple sclerosis. N. Engl. J. Med. 28:2000;938-952.
18. Peterson J.W., Bö L., Mörk S., Chang A., Trapp B.D. Transected neurites, apoptotic neurons, and reduced in inflammation in cortical multiple sclerosis lesions. Ann. Neurol. 50:2001;389-400.
19. Quevedo C., Alcázar A., Salinas M. Two different signal transduction pathways are implicated in the regulation of initiation factor 2B activity in insulin-like growth factor-1-stimulated neuronal. J. Biol. Chem. 275:2000;19192-19197.
20. Rivera-Quiñones C., McGavern D., Schmelzer J.D., Hunter S.F., Low P.A., Rodriguez M. Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nat. Med. 4:1998;187-193.
21. Schierle G.S., Hansson O., Leist M., Nicotera P., Widner H., Brundin P. Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nat. Med. 5:1999;97-100.
22. Steinman L. Multiple approaches to multiple sclerosis. Nat. Med. 6:2000;15-16.
23. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science. 281:1998;1312-1316.
24. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mörk S., Bö L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338:1998;278-285.
25. Trapp B.D., Ransohoff R., Rudick R. Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr. Opin. Neurol. 12:1999;295-302.